The total return over the past 12 months is +49.98% vs. +19.98% for the S&P 500. So far it's up +28.04% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +43.15% | +2.51% | +0.37% | +1.72% | +5.72% | +5.49% |
| Total Return CAGR | +49.98% | +7.42% | +4.56% | +5.37% | +9.34% | +9.53% |
| Revenue CAGR | +3.11% | +2.87% | +2.08% | +10.81% | +6.06% | +4.78% |
| Net Income CAGR | +83.84% | +5.24% | +43.93% | +12.46% | +7.09% | +6.09% |
| EPS CAGR | +82.66% | (5.56%) | +9.38% | +13.56% | +4.41% | +4.13% |
| Free Cash Flow CAGR | (21.53%) | (0.78%) | (0.95%) | +42.83% | +6.93% | +11.67% |
| Operating Cash Flow CAGR | (19.62%) | (0.37%) | (0.06%) | +25.25% | +7.13% | +9.68% |
| Dividends CAGR | +3.34% | +4.71% | +1.61% | +5.23% | +6.53% | +4.05% |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Bristol-Myers Squibb Company (BMY)
| Year | Start price | End price | BMY Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $53.94 | $66.82 | +28.04% | +13.55% | +14.49% |
| 2025 | $56.56 | $53.94 | +0.13% | +17.72% | (17.59%) |
| 2024 | $51.31 | $56.56 | +15.78% | +24.89% | (9.11%) |
| 2023 | $71.95 | $51.31 | (26.15%) | +26.19% | (52.34%) |
| 2022 | $62.35 | $71.95 | +19.00% | (18.17%) | +37.17% |
| 2021 | $62.03 | $62.35 | +2.89% | +28.74% | (25.85%) |
| 2020 | $64.19 | $62.03 | +0.39% | +18.37% | (17.98%) |
| 2019 | $51.98 | $64.19 | +27.86% | +31.22% | (3.36%) |
| 2018 | $61.28 | $51.98 | (12.91%) | (4.56%) | (8.35%) |
| 2017 | $58.44 | $61.28 | +7.72% | +21.70% | (13.98%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
